Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Cardiac Toxicity|Antitumor Drugs|Breast Cancer
Interventions: DRUG: Trastuzumab
Sponsor: Peking University Third Hospital